Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions
- Status
- COMPLETED
- Phase
- PHASE1
Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)
- Status
- COMPLETED
- Phase
- PHASE3
STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Talabostat and Cisplatin in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Talabostat in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of PI-88 in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Harvesting Cells for Experimental Cancer Treatments
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Karenitecin (BNP1350) to Treat Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Peptide Vaccination for Patients at High Risk for Recurrent Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.
- Status
- COMPLETED
- Phase
- PHASE3
Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
- Status
- COMPLETED
- Phase
- N/A
Phase II Trial of Allovectin-7® for Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)
- Status
- COMPLETED
- Phase
- PHASE2